Sulphonamides Dr. Anuradha nischal synthetic antimicrobial agents  simply called sulfa drugs Primarily Bacteriostatic drugs  Cellular & humoral immunity.

Slides:



Advertisements
Similar presentations
Chapter 20: Antimicrobial Drugs
Advertisements

Introduction to Antibiotics 1 st yr( Respiratory block) Prof. Azza Elmedany.
SULFONAMIDES Recognized since In clinical usage since 1935.
SULFONAMIDES Infectious Diseases Hussain Talal Bakhsh King Abdul Aziz University Faculty Of Pharmacy.
MACROLIDES Erythromycin Clarithromycin Azithromycin Mechanism of action Inhibit protein synthesis by binding to the 50 s subunit Antibacterial activity.
SULFONAMIDES Sulfonamides introduced in 1930s.
LEPROSY Caused by bacterium Patients are classified into infectious or noninfectious on the basis of the type and duration of disease and effects of therapy.
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms. ANTIBIOTICS Chemical.
FOLIC ACID SYNTHESIS INHIBITORS SULFONAMIDES and TRIMETHOPRIM
PHL 424 Antimicrobials 12th Lecture By Abdelkader Ashour, Ph.D. Phone:
Pharmacological Management of Respiratory tract infections.
Antibiotics Biotechnology II. Univ S. Carolina Antibiotics Disrupt Cell Wall Synthesis, Protein Synthesis, Nucleic Acid Synthesis and Metabolism.
Pharmacology-1 PHL 211 2nd Term 11th Lecture By Abdelkader Ashour, Ph.D. Phone:
Sulfonamides, trimethoprim and Quinolones
Introduction to Antibiotics Prof. Azza ELMedany Pharmacology Department.
Chemical Control Methods
1 Treatment of Urinary Tract Infections. Prof. Mohammed Saad Al-Humayyd Prof. Azza Hafiz El-Medany.
Kh Sadique Faisal Asst. Lecturer Northern University Bangladesh.
1. Fluoroquinolones Ciprofloxacin Norfloxacin Ofloxacin Lomefloxacin Trovafloxacin Levofloxacin Sparfloxacin Gatifloxacin Quinolones Nalidixic acid Urinary.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 87 Sulfonamides and Trimethoprim.
Quinolones Folic Acid Antagonists Urinary Tract Antiseptics.
Respiratory Tract infections. PROF. AzzA ELMedany Department of pharmacology.
SULFONAMIDES Chapter 19.
(Antimetabolites) Sulfonamides.
CHEMOTHERAPY  Antimicrobial chemotherapy  Antiviral chemotherapy  Antiparasitic Drugs  Cancer Chemotherapy.
Antibiotics and Antimicrobial Agents. Antibiotics and Antimicrobial Agents.
Antimicrobial Agents (Sulfonamides and Quinolones)
Introduction to Antibiotics 1 st yr( Respiratory block) Prof. Azza Elmedany.
Antibacterial Agents which Act Against Cell Metabolism
CLINICAL PHARMACOLOGY OF ANTIBACTERIAL AGENTS. Actions of antibacterial drugs on bacterial cells.
Urinary Antiseptics. Organisms  Escherichia coli  Proteus  Pseudomonas species  streptococci  Klebsiella  Enterococcus  Staphylococcus epidermidis.
CHLORAMPHENICOL First broad spectrum antibiotic. First broad spectrum antibiotic. Originally isolated in Originally isolated in Now produced.
1 Treatment of Urinary Tract Infections. PROF. AZZA El-Medany.
Notes for Pharmacology II practicals MUDr. Alena Máchalová Ph.D., PharmDr. Ondřej Zendulka, Ph.D.; Mgr. Jana Merhautová This study material is exclusively.
Antifolates, DNA gyrase inhibitors, Novel lipopeptides
Antimicrobial drugs. Antimicrobial drugs are effective in the treatment of infections because of their selective toxicity (that is, they have the ability.
Dreams of a “Magic Bullet”
PHARMA TEAM 428 ANTIBIOTICS(4) Pharma Team 428.
First effective chemotherapeutic agent
Chemotherapy Of Mycobacterial Infections Dr.Mohamed daood PhD student in Pharmacology.
Antimicrobials - Quinolones & Fluoroquinolones Antimicrobials - Quinolones & Fluoroquinolones Pharmacology -1 DSX 215 DSX 215 Dr/ Abdulaziz Saeedan Pharmacy.
Dr. Laila M. Matalqah Ph.D. Pharmacology
Treatment Of Respiratory Tract infections. Prof. Azza ELMedany Department of Pharmacology Ext
Sulfonamides:- 1)Oral absorbable – Short, intermediate, long 2)Oral non – absorbable 3)Topical Short: Sulfacytine, Sulfisoxazole, Sulfamethizole Intermediate:
Introduction to Antibiotics 1 st yr( Respiratory block) Prof. Azza Elmedany.
ANTIFOLATE DRUGS. Sulfonamides are derivatives of p -aminobenzoic acid (PABA)
1 Treatment of Urinary Tract Infections. PROF. AZZAEl-Medany And Dr Ishfaq Bukhari.
Antimicrobials - Sulfonamides Antimicrobials - Sulfonamides Pharmacology -1 DSX 215 DSX 215 Dr/ Abdulaziz Saeedan Pharmacy College Pharmacy College 1.
Antibiotic Therapy-1 -Lecture Objectives Introduction Antibiotics-Targets, Problems of Resistance, Administration, Tissue Distribution Sulfonamides & Cotrimoxazole.
Treatment of Respiratory Tract infections. Prof. Azza EL-Medany.
PRINCIPLES OF ANTIBIOTIC THERAPY
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms. ANTIBIOTICS Chemical.
Antibiotics By Alaina Darby.
Protein Synthesis Inhibitors
Folate Antagonists Enzymes requiring folate-derived cofactors are essential for the synthesis of purines and pyrimidines (precursors of RNA and DNA) and.
أ . م . د. وحدة بشير اليوزبكي Head of Department of Pharmacology- College of Medicine- University of Mosul-2014 Sulphonamides 6.
Miscellaneous Antibiotics
  Antimetabolites: Sulfonamides Sulfonamides can be divided into three major groups: (1) oral, absorbable; (2) oral, nonabsorbable.
Lecture 1 Antimicrobial drugs.
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms . CHEMOTHERAPEUTIC.
Cephalosporin and Other Cell Wall Synthesis Inhibitors
Sulfonamides and Quinolones
Sulfonamides and Quinolones
Sulfonamides صيدلانية نظري / د . فارس رابع صيدلة 23 / 4 / 2016
Folate Antagonists Enzymes requiring folate-derived cofactors are essential for the synthesis of purines and pyrimidines (precursors of RNA and DNA) and.
Macrolides(Erythromycin )
Synthetic antimicrobial drugs
Fluoroquinolone Nalidixic acid is the predecessor to all fluoroquinolones, a class of man-made antibiotics. Fluoroquinolones in use today typically offer.
Antimetabolites ( Sulfonamides )
ANTIBIOTICS They are divided into four categories based on their bacteriostatic or bactericidal effect(mode of action) on various structures and macromolecules.
Presentation transcript:

Sulphonamides Dr. Anuradha nischal

synthetic antimicrobial agents  simply called sulfa drugs Primarily Bacteriostatic drugs  Cellular & humoral immunity of host is essential for eradication of the infection.

Spectrum Gram positive & Gram negative  Emergence of resistance  Usefulness has declined Susceptible microorganisms:  Streptococcus pyogenes  Streptococcus pneumoniae Nocardia, Actinomycetes, Calymmato bacterium granulomatis & Chlamydia trachomatis

H. influenzae H. Ducreyi Organisms now Resistant N. Meningitidis - Serogroups A, B, & C Shigella E.Coli

Mechanism of action

Competitive inhibitors of dihydropteroate synthase bacterial enzyme responsible for the incorporation of PABA into dihydropteroic acid immediate precursor of folic acid.

Pteridine + PABA/ sulpho.. Dihydropteroate synthase Dihydropteroic acid Dihydrofolic acid D ihydrofolate reductase Tetrahydrofolic acid

Folic acid is used for the synthesis of purines and thymine  Required for formation of DNA  Therefore folic acid is required for replication of cellular genes. Important function of folic acid is to promote growth so in its absence organism grows very little.

Sulfonamides are Also k/a anti-metabolites  i.e. They block the essential enzymes of folate metabolism.

Mechanism of action Structural analogues of PABA (para- amino benzoic acid) Sulfonamide gets incorporated to form an altered folate which is metabolically injurious.

Sensitive micro-organisms are those that must synthesize their own folic acid. Bacteria that can use preformed folate are not affected. Bacteriostasis induced by sulfonamides is counteracted by PABA competitively.  Pus rich in PABA  Efficacy is lost Mammalian cells are not affected, they require preformed folic acid and cannot synthesize it

Absorption, Fate & Excretion Absorbed rapidly from GIT  Small intestine(major site) & stomach PPB variable, albumin, Distributed throughout the body  Readily enter pleural, peritoneal, synovial, ocular fluids  Conc % that in blood

Readily cross placenta (antibacterial + toxic effects) Metabolised in liver, Excreted in urine  Small amounts in faeces, bile, milk and other secretions.

Classification Agents that are absorbed & excreted rapidly  Sulfisoxazole  Sulfamethoxazole  Sulfadiazine Agents that are absorbed very poorly when administered orally, hence active in bowel lumen  Sulphasalazine

Long acting sulphonamides absorbed rapidly excreted slowly  Sulfadoxine Agents used topically  Sulfacetamide  Mafenide  Silver sulfadiazine

Pharmacological properties of Individual Sulphonamides Sulfisoxazole Rapidly absorbed & excreted sulfonamide with excellent antibacterial activity Half life 5-6 hrs High solubility, no crystalluria Replaced less soluble agent. Bactericidal activity in urine.

Sulfisoxazole acetyl Tasteless – oral use in children Fixed dose combination with erythromycin ethylsuccinate for children with otitis media.( phenazopyridine in mixture(UA & analgesic; urine red.)

Sulfamethoxazole Close congener of sulfisoxazole Half-life :8-12 Hrs Fixed dose combination with trimethoprim High fraction is acetylated, which is relatively insoluble crystalluria can occur. Precautions to avoid crystalluria

Poorly absorbed sulfonamides Sulfasalazine poorly absorbed from GIT Active in bowel lumen Ulcerative collitis, regional enteritis Intestinal bacteria - sulfapyridine (toxic) +5 aminosalicylate (effective agent in IBD)

Sulfonamides for topical use Sulfacetamide Extensively-management of Opthalmic infections (Trachoma/Inclusion conjunctivitis)  Penetrates ocular fluids & tissues in high concentrations.  Advantage: very high aqueous conc. not irritating to eyes & are effective against susceptible microorganisms.

Sulfacetamide sodium 10-30%

Silver Sulfadiazine Inhibits growth of nearly all pathogenic bacteria & fungi Used topically to reduce incidence of infections of wounds from burns  Slowly releases silver ions - antimicrobial action  DOC for prevention of infection of burns.

Mafenide Prevention of colonization of burns by a variety of gram negative & gram positive bacteria  Limited usefulness: inhibits carbonic annhydrase metabolic acidosis

LONG ACTING SULFONAMIDES Sulfadoxine Long acting Half-life :7-9 days Combination Sulfadoxine 500mg + Pyrimethamine 25 mg Prophylaxis & treatment of malaria caused by chloroquine resistant strains of plasmodium falciparum.

Falciparum Malaria Pyrimethamine  Inhibits Plasmodial DHFRase Supraadditive synergistic combination with pyrimethamine due to sequential block  Combination acts faster  Development of resistance to pyrimethamine is retarded.

Clinical curative Three tablets single dose Both long half-life Advantage of combination Good compliance due to single dose therapy

Resistance to sulfonamides Resistant mutants  Produce increased amounts of PABA  Their Folate synthetase enzyme has low affinity for sulfonamides  Adopt alternate pathway of folate metabolism.

Crystalluria Older, less soluble sulphonamides Insoluble in acidic urine Precipitate, forming crystalline deposits that can cause urinary obstruction.

Fluid intake sufficient to ensure a daily urine volume of at least 1200ml Alkalinization of the urine if pH low Sulfisoxazole more soluble, incidence of this problem is low

kernicterus Administration to newborn infants esp. premature  Sulfonamides displace bilirubin from plasma albumin.  Free bilirubin is deposited in basal ganglia & sub-thalamic nuclei of the brain causing an encephalopathy called kernicterus.

Hypersenstivity reactions Acute hemolytic anaemia in G- 6PD deficient patient Agranulocytosis - sulfadiazine Aplastic anaemia Anorexia, nausea, vomiting

Potentiate the effect  Oral anticoagulants  Sulphonylurea hypoglycaemic agents  Hydantoin anticonvulsants Inhibition of metabolism of these drugs + displacement from albumin. Dosage adjustment

Cautious use in patients with impaired renal functions.

Urinary tract infections  No longer therapy of first choice  Quinolones  Co-trimoxazole  Fosfomycin  Ampicillin  Urinary antiseptics

Nocardiosis  Sulfisoxazole/Sulphadiazine;  DOC  Complete recovery with adequate treatment  6-8 g daily/ µg/ml  Schedule continued for several months after all manifestations have been controlled.

Toxoplasmosis  Pyrimethamine-sulphadiazine combination is Tt of choice  Pyremethamine loading dose- 75 mg 25 mg orally per day  Sulphadiazine 1 g orally every 6 hrs.  Folinic acid 10 mg orally every day. For 3-6 weeks.  2 litres of fluid intake daily.

Prophylaxis & treatment of malaria Prophylaxis of streptococcal infections in patients hypersensitive to Penicillin.  DOC is Penicillin.  Sulphonamides are as efficacious  Should be used without hesitation in patients hypersenstive to penicillins

Topical uses Used extensively in the management of Opthalmic infections Used topically to reduce incidence of infections of wounds from burns, DOC. Ulcerative collitis, regional enteritis

COTRIMOXAZOLE Sulfameth oxazole Trimeth oprim Cotrimo xazole

Sulfamethoxazole competitive inhibitors of dihydropteroate synthase Trimethoprim Trimethoprim inhibitis dihydrofolate reductase prevents reduction of dihydrofolate to tetrahydrofolate

Pteridine + PABA D ihydropteroate synthase Dihydropteroic acid Dihydrofolic acid D ihydrofolate reductase Tetrahydrofolic acid

Acts on Sequential steps Synergism Two drugs interfere with two successive steps in the same metabolic pathway& produce supraadditive effect. (Sequential blockade) Individually both are bacteriostatic but the combination has cidal effect Chances of development of bacterial resistance are also greatly reduced

Pk properties of both the drugs match closely

Synergism Optimal ratio of the concentrations of the two agents for Synergism 20:1  Sulfamethoxazole : Trimethoprim Combination is formulated to achieve a sulfamethoxazole conc. in vivo 20 times greater than that of trimethoprim Trimethoprim times more potent Dose ratio  5:1; S: 800 mg; T: 160mg

Trimethoprim is a highly selective inhibitor of DHFRase of lower organisms Approx. 1,00,000 times more drug is required to inhibit human DHFRase than than bacterial enzyme  Do not interfere with folic acid metabolism in human beings Mammalian cells preformed folate from the diet

Spectrum Broad spectrum  Both Gram negative & Gram positive Combination: Chlamydia, diptheriae, N. meningitidis S. aureus, S. pyogenes, proteus, Pneumocystis carinii, Salmonella typhi, shigella, Klebseilla, Resistance can develop when trimethoprim is used alone

Resistance to co-trimoxazole is reportedly formed in almost 30 % of urinary isolates of E. coli.

Resistance Mutational Plasmid mediated acquisition of altered DHFRase having low affinity for trimethoprim.

Adverse effects

No evidenve of folate deficiency in normal person at the recommended doses Folate deficiency can occur in patients deficient in folate in diet:  Megaloblastosis,  leukopenia,  thrombocytopenia,

Hypersensitivity reactions involving skin  AIDS patients frequently have hypersenstivity reactions with co-trimoxazole Nausea vomiting Glossitis Stomatitis CNS: headache,depression, etc

Therapeutic Uses

Urinary tract infections Uncomplicated lower urinary tract infections  Highly effective for enterobacteriacae S: 800 mg; T: 160mg;  2 tablets single dose; effective  Minimum of 3 days therapy is more likely to be effective.

Chronic & Recurrent UTI Women in reproductive age group Post coitally.  S; 200 mg +T; 40 mg/day.  Or 2-4 times once/twice per week. Presence of trimethoprim in vaginal secretions. Bacterial prostatitis Presence of therapeutic concentrations of trimethoprim in prostatitic secretions

Respiratory tract infections Acute & chronic bronchitis Acute otitis media in children Acute maxillary sinusitis in adults d/t S. pneumoniae & H. influenzae (if susceptible)

GI tract infections Alternative to fluoroquinolone for treatement of Shigellosis. Second line drug for typhoid fever.  Seldom used  Ceftriaxone/ FQs preferred

Infection by Pneumocystis carinii/ jiroveci in neutropenic & AIDS patients Causes severe pneumonia in these patients High dose therapy T mg/kg/day,S mg/kg/day is effective for infection by pneumocystis jiroveci infection in patients with AIDS.

Miscellaneous:  Nocardia  Whipple’s disease  Wegener’s granulomatosis

THANK YOU